Fukunaga, Atsushi http://orcid.org/0000-0003-2026-8154
Oda, Yoshiko http://orcid.org/0000-0002-5244-0871
Imamura, Shinya http://orcid.org/0000-0001-8670-4997
Mizuno, Mayuko http://orcid.org/0000-0002-8530-1720
Fukumoto, Takeshi http://orcid.org/0000-0003-0364-711X
Washio, Ken http://orcid.org/0000-0002-2468-7535
Funding for this research was provided by:
JSPS KAKENHI (20K08651)
Article History
Accepted: 26 August 2022
First Online: 15 September 2022
Declarations
:
: This work was supported in part by Japan Society for the Promotion of Science KAKENHI (Grant number 20K08651).
: AF has received fees for speaking from Novartis, Sanofi, Takeda, Tanabe-Mitsubishi, Kyowa-Kirin, Kyorin, Kaken, and Taiho. AF has also received funds for sponsored/joint research from Novartis and Taiho. KW has received fees for speaking from Sanofi, Maruho, Novartis, Taiho, Tanabe-Mitsubishi, Kyowa-Kirin, and AbbVie. YO has received fees for speaking from Janssen Pharm. The other authors have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Consent was obtained from the patient in the presented photograph.
: Not applicable.
: Not applicable.
: AF had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. YO, SI, MM, and TF drafted the manuscript. KW supervised the conduct of this study. All authors reviewed the manuscript draft and revised it critically for intellectual content. All authors approved the final version of the manuscript to be published.
Free to read: This content has been made available to all.